Astellas Pharma Inc. · TSE:4503
Astellas Pharma — Investor Presentation (July 2022)
42 slides from Astellas Pharma's investor presentation, Jul 8, 2022
Slide 1: I ABOMBEGIC DWT
I ABOMBEGIC DWT eke Faz N—F v JURE Bleisett (BESET 4 0530) “Wastellas
Slide 2: FY2021 results review
| «Hons 2 20218 BRRAOME 252021 MFEORVIEY “Wastellas
Slide 3: j zen
j zen 3 COBARICaARMeN CT SHEOHE, . ER, FEICM DT Sack LO FD OWLO RS COL aMlL Ao 5 AROS CING BIRD ABLCT,. CNSORMAHRSROREAFARCBRICRO<ARBUYD REICKStEODCHY, BABE LOURMOURZT EMERCEREBA CURT. BRAN EBAICKIT. CH SRRO Ais LISRRORRCAS < BSS ARettD HVKT,. TOBZACUTS. (i) Rep wlC6ISSRRROZLSBLV BAAR BIOCUE. (i) AB
Slide 4: FY2021 results
J «Aone : 202158 BRRAOME HHH2021 MFROMRIBY Wastellas
Slide 5: FY2021 results
j eH (aPx-2) 5 = =I THU BATE B awn y WHS IATA eye cs +t Mm 12,962 +466 +3.7% 5 ER 2,530 +69 +2.8% co # Fl & 10,432 +397 +4.0% it 5,488 +445 48.8% eae | 2,460 +215 +9.6% IV BSF 2,447 -66 -2.6% 17 34 BA Hl 2s 1,906 -193 -9.2% “Wastellas
Slide 6: FY2021 results
f eH (DVA-2) 6 aia Ss TIRES se BtaR RLS cS fF Mm 2 12,962 +466 +3.7% Bk FH f& 1,557 +196 +14.4% Mi 5] ao Fl tt 1,569 +116 +8.0% 4 FH 1,241 +35 +2.9% Wastellas
Slide 7: FY2021 results
J «Aone d 2021FE SERRAOME 252021 MFEORUIEY “Wastellas
Slide 8: Strategic Plan 2018 and 2021 vision
] @221820210R= : f=S5tH2018 =StH2021 VISION (CL EMRR. OKO. ERSG| SC TRIN. VISIONRRA DHSS SRS ffi (8 ORGER Pe te El i preven jie be + lt A i mit J= PIbAAZIBRG SEBIE AWATPIAT LEAT S, I2Zk AYR BR Wastellas *"What Is Value in HealthCare?” Porter, M.E. (2010). New England Journal of Medicine KU
Slide 9: Focus Area approach
| amas : Peis TRACERS 2519S eerew: me XTANDIRUE RS igson'O Mie) OmAIE Av Focus ArearJO—FICHIIS SS wee COT) N—YAYORR cn SIME GMMIICMBOPOL II hOB Rx+ EVYRADER e2seeue. eae EEBAO?T ARAM EIXl SRS eMR Ie areeiwmms be iret LC aeoaaik “Wastellas * VANI®, NERD®, TNLUY®, fezolinetant, VVAYFUVI, AT132
Slide 10: | eee
| eee 10 Hoes 5 erICre We XTANDIRUS AMBER ME) OBA Ave Focus AreayJO—FicdltS ee Tee Seem? J N—-DAYORA ees AES HBMEPICBROTOL II bh ORR enim REERAOT I RAR L IX RAEN Ie onugaeat PES ce teem tt cca a Wastellas * YVAZN9®, NERDS, LNLYUY®, fezolinetant, WUNAYFLUVI, AT132
Slide 11: Results of strategic products
| Lass ssmsROwL RASS XT AU RATS RA 11 (fis) (4F5) lela XTANDI/ 5,343 +759 +16.6% TIAVII i TE HG TE th fs 2 A YRN YF 341 +102 +42.9% REERAR A SR A 0 Bt 4m 8 wm # Wastellas
Slide 12: | S5uBeTOMAOTVER
| S5uBeTOMAOTVER 12 JOVIFZE/Rm LYYIWVIY=K/ XTANDI 1B AE (ERIN) IE ABIS 2 (KE) LYURIVYVDT NEFYU/NERD = |e (ERM) a4 (4s) OFUFAZVYR/INDIUY 7K5B'S (BRM) fezolinetant SBA’ 5257 —IME AT132 BaPRaee ? = LIED HRS 1 RSENVEVBSUMUMIA, 2 VATSF URE CAREOHSEBERELBDA, *3 AEWA KUPD-1/L1MEMOGMEODSHBERBLEDA, *4 DAC PR
Slide 13: | eee
| eee 13 — PRAYERS SIT S ew XTANDIROS AMER O Miia) ORAL sicaplached Focus AreaVYJO—FICKIFS HEOESE aus aoe eae Sent /K—-VAVORR ASABE PICMBOTO LT KORE . Peet Vs RaERAO?P AIRARMEIK MRS SMR Ie Ones Besoe eee tie cla Wastellas * YVAZN9®, NERDS, LNLYUY®, fezolinetant, WUNAYFLUVI, AT132
Slide 14: Focus Area pipeline
| Focus Areav JO—FOZFEBER Primary Focus SARA * | BRERA Y 14 *1 IND GaBRSTRRRGS) /BRPRRASEIC IIT 7S rade L ERR ORL *2 ASP1570, *3 ASP2138, *4 ASP8731, *5 ASP3082 , *6 PoC: AYLTH RE (RHMEAOEROSIESHMT SEMOMARMRT —F) 1 2 1 (DGK ¢ BAS Al*2, BHA) 1 1 1 (BACH 1 BBS #i*4) Primary Focus (&#i, 5 1 =EMtth (NY
Slide 15: | eee
| eee 15 ee PRaNMRewssS cores me XTANDIROS Ree eon"O MiG) OmAIt Mew Focus AreaPIO—FICSIIS TM ee BROT / N—YAYORR ACEHDMHICBBROVOL TI KORE -- _ at RaERAO?P AIRAMEIK MRS EMR Ie paipreeeevmms Fars seeat L CARoraaib Wastellas * YVAZN9®, NERDS, LNLYUY®, fezolinetant, WUNAYFLUVI, AT132
Slide 16: Product name and classification
販売名 マイホルターⅡ 一般的名称 ホルタ解析装置用プログラム クラス分類 クラスII（管理医療機器）
Slide 17: | eee
| eee BRA BACAOLU RU PIFLALORR PGE 2 AFOESE HEA Mii] A BRB tR3 Rx+ EVRADIER Bune BR 4 PATFEUT IAL OR) Hos Za 17 PRA SKRABSITS XTANDIRUERE Rano Mihi) ORAL Focus AreavJO—FIcSItS RIOT IN—YVAVORR AEH AICHBOPOVIID KORE EER AO?T 7 PARMLICIMRS ae I= pec L CEs Wastellas * YVAZN9®, NERDS, LNLYUY®, fezolineta
Slide 18: Product pricing and access programs
| SHNVAERRICHNI SRSOAFAREMSSAT 812 LD 2 BARRIOS L 2 YANI : 35nBTIOOAMLE | NERD: 7THBC270OAKE PHPIRAPTOFSL XTANDI/4 JA9VY : 244 HC3008GWE _— TEIN YANG: 9nBTAOARLE ED ies: 10nBICIOAILE NET: 50a HI CH3Z0A a International Pharmacy Program & International Import Program XTANDI/4 JA9VY374AB. VANI17T4AB —
Slide 19: Targets
| Ree 19 1.58 Eunés > XTANDIRU a eehhon* Oselis 2025E1C139b2,000f ALE 2.NI F574 Vitis : Focus AreavOUrIkAYSO ZLIF2030FEIc 5,000RALE 3.17 BRR : 2025FEIC3O%UE NRARZENTSOCCC 2025HFE (CRRA TEA * YVAN9®, NERD®, LALYY®, fezolinetant, VWUNYFYUVI, AT132
Slide 20: I went
I went © KREEWS SEOOBRRAtRET 20 @ film: APA RORICBROS, REET 218 b ACS 2KEOSIS LIT © PRIASNE URL, ACES MINING 2B tH2021 OR Ald. SFM PCOS, KVR WKEORSS AES Bey 100 - © mn es IP BACAR OH y 0 a 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 6,000 3 Pee
Slide 21: Bits SERORI nN
Bits SERORI nN Weastellas
Slide 22: PWastellas
PWastellas
Slide 23: FETA — Ee BOF
1 me FETA — Ee BOF fase] OA~ 108
Slide 24: it oR
52 it oR BNE (ESSESCHSMHEER<) 6 Hi (EOl+E fASHAl 11 A~15
Slide 25: i oe
5 3 i oe maf Feed CO DANiw ix 3HiEIEOH fASHAl 16R~18AR
Slide 26: PWastellas
PWastellas
Slide 27: Sikhs
Sikhs a PAF FARRRASA S| 7MERRERS RATER Hs Fic (6-5 - RMLOMTHA) DESUMERM EATELET. HI SMR |e B2SHR [7B] 1[/z iW @ alx|s 2/5 # 6 wee PRBS TUS AR =» 3 8 w all TOEYVECIUMITCEAU. 4;3 8 @ 2 els [s\e > # a|e|s 6) % # Bey le) es ,_ 835m | __ 1|\5 * 4 |e) es [2|= mB x|n/a 3/> w k miele O85 - RHOUTNICBOMORA MB
Slide 28: FETA — Ee BOF
1 me FETA — Ee BOF fase] OA~ 108
Slide 29: it oR
52 it oR BNE (ESSESCHSMHEER<) 6 Hi (EOl+E fASHAl 11 A~15
Slide 30: i oe
5 3 i oe maf Feed CO DANiw ix 3HiEIEOH fASHAl 16R~18AR
Slide 31: Re SHWWUELES
Re SHWWUELES
Slide 32: PWastellas
PWastellas
Slide 33: Under confirmation
Slide 34: ERK — Bb oe SOF
1 me ERK — Bb oe SOF fase] OA~ 108
Slide 35: bp ie ae
bp 1 ie ae ETA — Eb OTF fASaA OA~ 10
Slide 36: it oR
52 it oR BNE (ESSESCHSMHEER<) 6 Hi (EOl+E fASHAl 11 A~15
Slide 37: bh it
bh 275 it Wiis (SESES CHSMMEER<) 64 2EOF fASHA] 11R~15e
Slide 38: i oe
5 3 i oe maf Feed CO DANiw ix 3HiEIEOH fASHAl 16R~18AR
Slide 39: bh OS ie
bh OS ie Gat wFoced CO OAH 3HiEIEO fASAl 16R~18A
Slide 40: PWastellas
PWastellas
Slide 41: less l(SdSIFS sO < TES.
less l(SdSIFS sO < TES. Wrastellas es . <a FIABRAAS AL » astellas
Slide 42: PWastellas
PWastellas